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RABIES-EPIDEMIOLOGY, PREVENTION, AND 
FUTURE RESEARCH 
JOHN W. KREBS, MARK L. WILSON, AND JAMES E. CHILDS 
Viral and Rickettsial Zoonoses Branch, National Center for Infectious Diseases, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE, 
Atlanta, GA 30333 (JWK, JEC) 
Department of Epidemiology and Public Health, School of Medicine, 
Yale University, 60 College Street, New Haven, CT 06520-8034 (MLW) 
Rabies is caused by a single-stranded, negative-sense RNA virus, maintained in nature by 
a variety of animal reservoirs. Rabies virus infects the central nervous system, resulting in 
progressive encephalopathy and ultimately death in an infected human. Globally, the risk 
of contracting rabies for humans is greatest in regions of the developing world where dog 
rabies is enzootic. Where rabies in dogs has been eliminated or otherwise controlled through 
vaccination programs, the disease can be maintained by wildlife. Wildlife primarily in- 
volved in maintenance of transmission cycles are carnivores and bats. Persons having fre- 
quent contact with wildlife, such as mammalogists, are at greater risk than the general 
population for exposure to rabid animals. Rabies prevention can be achieved by elimination 
of exposure and by vaccination through preexposure prophylaxis and postexposure treat- 
ment. Preexposure rabies prophylaxis affords a measure of protection for unrecognized 
rabies exposures and simplifies postexposure treatment. Postexposure treatment is recom- 
mended following exposure to a potentially rabid animal and involves treatment of wound 
and administration of rabies vaccine as well as rabies immune globulin for individuals not 
previously vaccinated. Future research on rabies is necessary to define the effects of infec- 
tion on wildlife populations and to evaluate the potential for intervening in wildlife trans- 
mission using oral rabies vaccines. 
Key words: rabies, Lyssavirus, Rhabdoviridae, zoonoses 
The antiquity of rabies is illustrated by 
the ancient origins of terms describing this 
disease. The Latin word "rabies" is be- 
lieved to derive from the Sanskrit "rab- 
has," meaning "to do violence." Early rec- 
ognition of the infectivity of the saliva of 
rabid dogs led Roman writers to describe 
the infectious material as a poison, for 
which the Latin word was "virus" (Steele 
and Fernandez, 1991). Lyssavirus, the ge- 
nus to which rabies and rabies-related vi- 
ruses belong, owes its name to the Greek 
"lyssa" or "lytta," meaning "madness." 
The first recorded description of canine ra- 
bies apparently was made by Democritus 
ca. 500 B.C. Aristotle, writing of rabies in 
his Natural History of Animals, described 
dogs suffering from a madness causing ir- 
ritability and how following their bite other 
animals became diseased. Little has 
changed in the epidemiology of rabies, as 
dogs and other carnivores remain the com- 
mon sources of human infection in most ar- 
eas of the world where the virus is enzootic. 
CHARACTERISTICS OF LYSSAVIRUSES 
Rabies and rabies-like illnesses are 
caused by a number of different neurotropic 
viruses belonging to the genus Lyssavirus 
in the family Rhabdoviridae. The rabies vi- 
rion consists of single-stranded, negative- 
sense RNA contained within a bullet- 
shaped, bilayered envelope. The genome 
encodes five structural proteins. Three of 
these, the transcriptase, nucleoprotein, and 
phosphoprotein complex with the genome 
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to form an inner nucleocapsid. The matrix 
protein forms the inner side of the bilayered 
lipid envelope and the glycoprotein forms 
the outer layer and spike-like projections, 
the target of virus neutralizing antibody 
(Wunner et al., 1988). 
Members of the genus Lyssavirus have 
been subdivided into serotypes or geno- 
types (GT) on the basis of studies of neu- 
tralization and monoclonal antibodies or ge- 
netic characterization. The classical strains 
of rabies virus belong to serotype 1 (also 
GT 1). Other rabies-related viruses include 
Lagos bat, Mokola, and Duvenhage viruses, 
constituting GT 2, 3, and 4, respectively. 
Serotype 5 originally was proposed to ac- 
commodate European bat lyssaviruses 
(EBLV 1 and 2). However, these eventually 
were shown to be genetically different and 
have been proposed as GT 5 and 6, respec- 
tively (Baer and Smith, 1991; Bourhy et al., 
1993). 
Classical rabies viruses are present 
worldwide with the exception of some is- 
lands and areas inaccessible or inhospitable 
to wildlife that might serve as hosts. The 
known distribution of GT 2-6 is described 
from only a few isolates and, thus far, is 
confined to Africa, Europe, and the former 
Soviet Union. Fatal rabies-like human ill- 
nesses have been associated with several of 
these other lyssaviruses, including Mokola 
virus (GT 3), isolated from insectivores 
(Suncus), rodents, and domestic dogs and 
cats in East, West, and southern Africa 
(Familusi et al., 1972; Foggin, 1983; Ogun- 
koya et al., 1990; Saluzzo et al., 1984; Sho- 
pe et al., 1970); Duvenhage virus (GT 4), 
isolated from a man bitten by a bat (species 
unknown) in Pretoria, South Africa (Mere- 
dith et al., 1971); Yuli virus, isolated from 
a boy bitten by a bat (species unknown) in 
the former Soviet Union (Selimov et al., 
1989) appears most similar to EBLV 1 (GT 
5; C. E. Rupprecht and J. S. Smith, pers. 
comm.), isolated from Eptesicus serotinus 
in Holland (Nieuwenhuijs et al., 1992); 
EBLV 2 (GT 6), isolated from a Swiss re- 
searcher of bats in Finland (similar isolates 
have since been obtained from Myotis da- 
sycneme-King and Turner, 1993). While 
not known to be responsible for any human 
deaths, Lagos bat virus (GT 2) was isolated 
from Eidolon helvum in Nigeria (Bougler 
and Porterfield, 1958). 
VIRAL TRANSMISSION 
Rabies virus is transmitted by its intro- 
duction into wounds or cuts in skin or mu- 
cous membranes, most commonly by bites. 
Transmission of rabies virus also may oc- 
cur, under unusual circumstances, via non- 
bite exposures. The nonbite exposures of 
apparent highest risk are those from large 
amounts of aerosolized rabies virus, organs 
(i.e., corneas) transplanted from patients 
who died of rabies, and contact of saliva or 
nervous tissue from a rabid animal with 
mucous membranes or scratches (Centers 
for Disease Control and Prevention, 1991). 
Two cases of rabies have been attributed 
to airborne exposures in laboratories (Cen- 
ters for Disease Control and Prevention, 
1977; Winkler et al., 1973), and two cases 
of rabies have been attributed to airborne 
exposures in a bat-infested cave in Texas 
(Constantine, 1967). The only documented 
cases of rabies caused by human-to-human 
transmission occurred in eight recipients of 
transplanted corneas. Investigations re- 
vealed that each of the donors had died of 
an illness compatible with or proven to be 
rabies (Centers for Disease Control and 
Prevention, 1980, 1981; Gode and Bhide, 
1988; Houff et al., 1979; World Health Or- 
ganization, 1994). The eight cases occurred 
in Thailand (two cases), Iran (two cases), 
India (two cases), United States (one case), 
and France (one case). Stringent guidelines 
for acceptance of donor corneas have re- 
duced this risk. Although bites inflicted by 
infected humans theoretically could trans- 
mit rabies, possible cases are poorly docu- 
mented (Helmick et al., 1987). 
HUMAN AND ANIMAL DISEASE 
Rabies virus preferentially infects ner- 
vous tissue. After inoculation, virions may 
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remain temporarily inactive or initiate at- 
tachment to the plasma membrane of pe- 
ripheral nerve cells. There is evidence of 
replication of the rabies virus in skeletal 
muscle cells near the site of inoculation pri- 
or to infection of nerve cells (Balachandran 
and Charlton, 1994). The nervous-tissue 
pathway of infection may shield the virus 
from the immune system, thus, accounting 
for the lack of early antibody response. The 
virus spreads by retrograde axoplasmic flow 
until it reaches the spinal cord and then rap- 
idly disseminates through the central ner- 
vous system. There then begins a reverse 
dissemination of virus along peripheral 
nerves to sites throughout the body, includ- 
ing the salivary glands, where it is shed in 
the saliva. 
The incubation period of rabies in hu- 
mans is variable; well-documented incuba- 
tion periods range from <10 days to >6 
years (Fishbein, 1991; Smith et al., 1991). 
In most cases, however, the first symptoms 
of rabies are noted within 30-90 days of 
exposure. Initial symptoms can include pain 
or paresthesia (abnormal touch sensation, 
such as burning) at the site of the wound, 
followed by fever, headache, malaise, and 
apprehension. As disease progresses, 
changes in mental status may occur includ- 
ing disorientation, agitation, hallucination, 
and, rarely in humans, aggression. Physical 
manifestations may appear in the form of 
difficulty swallowing, hypersalivation, pri- 
apism (persistent erection of the penis), 
muscle spasms, and ultimately paralysis. 
Hydrophobia occurs in fewer than one-half 
of all human cases. The progress of the dis- 
ease, once symptoms appear, is relentlessly 
downhill. Death may occur in 51 week, 
following the development of initial symp- 
toms, usually as a result of respiratory fail- 
ure. Ventilatory support may prolong sur- 
vival, but, in spite of experimental use of 
interferon and other antiviral drugs, no ef- 
fective treatment exists once the infected in- 
dividual becomes symptomatic (Fishbein, 
1991). 
Although almost universally fatal, there 
have been four well-documented instances 
of survival from rabies of persons whose 
infections had progressed to clinical dis- 
ease. All four persons had received vaccine 
either prior to exposure or during the in- 
cubation period, and at least two remain af- 
fected by sequelae (Alvarez et al., 1994; 
Centers for Disease Control and Prevention, 
1977; Hattwick et al., 1972; Porras et al., 
1976). 
NATURAL HISTORY AND 
EPIZOOTIOLOGY 
Rabies is a zoonotic disease, maintained 
and transmitted to humans by animal hosts. 
Human infections are of no importance to 
virus maintenance because humans do not 
normally contribute to the transmission cy- 
cle (Helmick et al., 1987). Mammalian car- 
nivores play the essential role as hosts for 
rabies virus in terrestrial cycles of the dis- 
ease. In most developing countries where 
rabies is enzootic, the domestic dog is the 
primary reservoir for the disease and the 
source for most human exposures. The ex- 
tent of rabies infection among wildlife in 
developing countries is unknown because 
of the overwhelming importance of canine 
rabies and incomplete surveillance among 
wildlife. Most developed countries have 
brought dog rabies under control through 
effective pet-vaccination programs. In these 
countries, the disease, when present, is- 
maintained among wildlife with only oc- 
casional transmission to domestic animals 
and humans. 
Across much of Europe, the red fox (Vul- 
pes vulpes) is the main reservoir while the 
raccoon dog (Nyctereutes procyonoides) 
and the gray wolf (Canis lupus) are reser- 
voirs in more northern regions of Eurasia 
(Wandeler et al., 1994). In Africa, jackals 
(Canis) and mongooses (Cynictis penicil- 
lata) as well as other carnivores are respon- 
sible for maintenance and transmission 
among wildlife (King et al., 1994). In North 
America, raccoons (Procyon lotor), skunks 
(primarily Mephitis mephitis), foxes (pri- 
marily V. vulpes), and bats (several species) 
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are the major reservoirs (Smith, 1989). Less 
is known about terrestrial wildlife reser- 
voirs in Central and South America due to 
the importance of dog rabies. Mongooses 
(Herpestes auropunctatus), introduced on 
some islands in the Caribbean (e.g., Puerto 
Rico), have provided wildlife reservoirs for 
rabies. Globally, rabies in bats is wide- 
spread and, although transmission cycles 
are distinct from those of terrestrial rabies, 
can spread to terrestrial mammals. Rabies 
in vampire bats (primarily Desmodus rotun- 
dus), which affects cattle and occasionally 
humans, is of special concern in regions of 
Central and South America (Lopez et al., 
1992; Pawan, 1936). 
Characterization of rabies-viral isolates 
by molecular-typing methods indicates that 
infections within broad geographic regions 
of the United States can be linked to dis- 
tinct viral variants, each primarily main- 
tained by intraspecific transmission within 
a dominant reservoir (Smith, 1989). Infec- 
tions among the diverse remaining mam- 
malian species of these regions generally 
are regarded as spill-over from the domi- 
nant reservoir species. The expected distri- 
bution of the variants affecting terrestrial 
species of animals has been established 
(Rupprecht and Smith, 1994; Fig. 1). Over- 
laying the disease in terrestrial animals are 
independent reservoirs for rabies in several 
species of insectivorous bats. The finding of 
a single variant in rabid raccoons from the 
southeastern states and the mid-Atlantic and 
northeastern states is compatible with the 
suggestion that transport of infected rac- 
coons from a long-standing focus of rabies 
in the southeastern states was responsible 
for the more recent epizootic in the mid- 
Atlantic and northeastern states (Jenkins et 
al., 1988). Rabies in skunks (mainly M. me- 
phitis) can be identified in three regions in 
the northcentral states, California, and the 
southcentral states. Rabies in foxes is rec- 
ognized in four regions. Although the num- 
ber of cases of rabies in gray foxes (Uro- 
cyon cinereoargenteus) in Arizona and Tex- 
as is small, distinctive variants identify res- 
ervoirs for rabies in these animals as 
independent of the more frequently reported 
disease in skunks in the same area (Krebs 
et al., 1994). The geographically-separate 
regions of rabies in Arctic (Alopex lagopus) 
and red foxes in Alaska and red foxes in 
the counties of New York and Vermont that 
border Canada are part of a much larger 
area of enzootic rabies extending across 
Canada from the Northwest Territories to 
Ontario. An epizootic of rabies in coyotes 
and affecting dogs in southern Texas is un- 
related to other reservoirs for rabies in Tex- 
as (Clark et al., 1994). European isolates of 
rabies are predominantly the red-fox-rabies- 
viral variant. The distribution of dog-rabies- 
viral variants throughout Africa and North 
and South America reflects their common 
origin and introduction via transportation of 
infected dogs by European colonizers 
(Smith and Seidel, 1993). Countries and 
other geographic entities, many of which 
are islands, reportedly free of terrestrial ra- 
bies at the time of this publication include 
Australia, New Zealand, Papua New Guin- 
ea, Japan, Hawaii, Taiwan, United King- 
dom, Ireland, mainland Norway, Sweden, 
Portugal, most of Pacific Oceania, and 
some Atlantic and Caribbean islands. 
Knowledge of the circulation of rabies 
variants in bats is less well developed than 
our knowledge of terrestrial variants. Ra- 
bies-viral variants circulating in bats are an- 
tigenically and genetically distinct from 
those associated with terrestrial carnivores 
and indicate independent transmission cy- 
cles of rabies (Smith, 1989). Rabies has 
been reported in >50 species of bats in the 
Western Hemisphere. In the southeastern 
and mid-Atlantic regions of the United 
States, the red bat (Lasiurus borealis) and 
other solitary species are found rabid most 
commonly. The yellow bat (Lasiurus inter- 
medius) and the Seminole bat (Lasiurus 
seminolus) also are important vectors in the 
southeastern states (Baer and Smith, 1991). 
In the Rocky Mountain, plains, and north- 
central states, the hoary bat (Lasiurus ci- 
nereus) and the big brown bat (Eptesicus 
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FIG. 1. Distribution of antigenic and genetic variants of rabies virus and the major species of 
terrestrial wildlife affected in the United States, 1993. Antigenic analysis was performed with a panel 
of monoclonal antibodies (MAbs) reactive with the rabies nucleoprotein. Filled boxes indicate a 
negative reaction by indirect immunofluorescent testing of infected brain material. Nucleotide (Nt) 
sequence of the nucleoprotein gene was obtained by direct sequencing of the cDNA product from a 
polymerase-chain reaction. 
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FIG. 2. -Cases of rabies in wild animals in the United States, 1955-1993. 
fuscus) are important vector species. The 
Brazilian free-tailed bat (Tadarida brasili- 
ensis) is an important vector in the south- 
western states. In the northeastern states, 
the big brown bat is most commonly re- 
ported rabid. The silver-haired bat (Lasio- 
nycteris noctivagans) is an important vector 
in the Pacific Northwest; rabies-viral vari- 
ants associated with this species have been 
identified with a number of human-rabies 
cases over a much broader geographic area 
(see section on epidemiology). 
In the Eastern Hemisphere, reports of 
bats infected with rabies-like viruses are 
fewer. Only 14 cases of infection with ra- 
bies-related viruses were reported in four 
species of bats during a 31-year period in 
Europe (Baer and Smith, 1991). These and 
subsequent cases spurred the examination 
of more bats, resulting in the discovery of 
more infected individuals during the past 10 
years. There have been only scattered re- 
ports of "rabid" bats from Asia and bats 
infected with rabies-related viruses from 
Africa (Bougler and Porterfield, 1958; Pal 
et al., 1980). 
The relative contribution of the different 
carnivores and bats to the maintenance of 
rabies in the United States has changed dra- 
matically since before the 1950s when dog 
rabies predominated. Foxes (U. cinereoar- 
genteus and V. vulpes) were the most fre- 
quently reported rabid species of wildlife 
until 1958, when reports of rabid skunks 
(primarily M. mephitis) first exceeded the 
declining annual numbers of cases reported 
in foxes (Fig. 2). From 1961 through 1989, 
the annual numbers of rabid skunks ex- 
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ceeded those of other wildlife. Beginning in 
1990 and continuing until the present, rac- 
coons have been the predominant species 
reported rabid. Following the first reported 
case of bat rabies in the United States in 
1953, the numbers of rabid bats increased 
and peaked at 1,038 in 1984 but, since then, 
have decreased, varying between 600 and 
800 annually (Krebs et al., 1994). 
During 1993, 49 states, the District of 
Columbia, and Puerto Rico reported 9,495 
cases of rabies in animals and three cases 
in humans to the Centers for Disease Con- 
trol and Prevention. Greater than 93% 
(8,889 cases) were among wildlife; 6.4% 
(606 cases) were domestic animals. This 
was the largest annual total of cases of ra- 
bies in wildlife ever reported by the Centers 
for Disease Control and Prevention and in- 
dicates the continuing problem of rabies in 
wildlife in the United States (Krebs et al., 
1994). Canine rabies was enzootic in coy- 
otes and unvaccinated dogs in 17 counties 
of southern Texas in 1994 (Clark et al., 
1994; Texas State Health Department, pers. 
comm.). The rabies virus variant involved 
has been present in the Texas-Mexico bor- 
der area since at least 1978. In late 1993, 
this variant was found in a rabid dog on a 
hunting compound in Alabama where trans- 
located coyotes from Texas had been re- 
leased (J. S. Smith, pers. comm.). This 
event is similar to the introduction of the 
raccoon-rabies variant into the mid-Atlantic 
states during the early to mid-1970s. Indi- 
viduals such as wildlife rehabilitators who 
transport animals, especially carnivores, 
must be aware of the potential for introduc- 
ing rabies and other zoonoses into areas 
where these diseases are not enzootic. 
Cats continue to be the domestic species 
most commonly reported rabid. This may 
be attributable to the lack of legislation in 
some states requiring vaccination of cats for 
rabies and the difficulty of enforcing laws 
where they exist. Other factors, such as 
high population densities of cats in subur- 
ban locations presumably place these ani- 
mals at greater risk for contacting wildlife 
in rabies-enzootic areas. 
Rodents and lagomorphs are among 
those animals least likely to be reported ra- 
bid, contributing <1% to the total cases re- 
ported in 1993. Woodchucks (Marmota 
monax) are the sole exception to this state- 
ment, accounting for >92% (59/64) of all 
cases reported in this group in 1993 (Krebs 
et al., 1994). 
EPIDEMIOLOGY 
Worldwide, most human rabies occurs in 
developing countries where canine rabies is 
endemic. Because effective rabies vaccines 
are available, most human deaths are pre- 
ventable but occur because public health re- 
sources and access to preventive treatment 
are limited. Cases of rabies are substantially 
underreported in most developing countries. 
This is exemplified by the fact that only 261 
laboratory-confirmed and 1,065 clinically- 
diagnosed cases of human rabies were re- 
ported to the World Health Organization for 
1991 (World Health Organization, 1993). 
However, unofficial estimates of human-ra- 
bies deaths of 2,000 in Bangladesh, 4,500 
in China, 6,500 in Pakistan, and 25,000 in 
India were provided by national represen- 
tatives at the Workshop on Rabies Control 
in Asian Countries in Samarkand (central 
Asia) on 19-21 September 1989. Rabies 
represents a serious public health problem 
in many regions of the world. 
In contrast, cases of human rabies in de- 
veloped nations have become increasingly 
rare. While the numbers of human-rabies 
cases in the United States exceeded 100/ 
year during the early 1900s, an annual av- 
erage of less than one indigenously-ac- 
quired case of human rabies has been re- 
ported over the past 30 years. However, 
control of rabies requires a complex and ex- 
pensive system of operations at local, state, 
and federal levels. It has been estimated that 
the cost of rabies control in this country 
exceeds $300 million annually (Fishbein 
and Arcangeli, 1987). 
An alarming trend in the epidemiology 
688 JOURNAL OF MAMMALOGY Vol. 76, No. 3 
of human rabies in the United States is the 
lack of information regarding the exposing 
event. From 1980 to 1994, 24 laboratory- 
confirmed cases of human rabies have been 
reported in the United States (two addition- 
al infections diagnosed in United States cit- 
izens working abroad occurred after dog 
bites). No history of animal bite was re- 
ported for 18 of the 24 cases (Centers for 
Disease Control and Prevention, 1994; 
Krebs et al., 1994; Viral and Rickettsial 
Zoonoses Branch, Centers for Disease Con- 
trol and Prevention, pers. obser.). Ten of 
these 24 infections were believed to have 
been acquired outside the United States, 
and dog-rabies-viral variants were implicat- 
ed by epidemiologic or genetic evidence. 
For 11 of 14 domestically-acquired cases, 
rabies-viral variants associated with bats 
were implicated by molecular typing (Cen- 
ters for Disease Control and Prevention, 
1994; Viral and Rickettsial Zoonoses 
Branch, Centers for Disease Control and 
Prevention, pers. obser.). All but three of 
these 11 variants were of the type associ- 
ated with the silver-haired bat, a species 
rarely submitted for rabies testing (Childs 
et al., 1994). In only one of these 11 cases 
was the exposure attributable to bat bite. 
The involvement of bat variants of rabies 
in eight of the last 10 indigenously-acquired 
infections of human rabies and >78% of all 
indigenously-acquired cases in humans 
since 1980 indicates the potential for hu- 
man disease, even with effective barriers 
that prevent transmission from terrestrial 
animals (Centers for Disease Control and 
Prevention, 1994; Krebs et al., 1994; Viral 
and Rickettsial Zoonoses Branch, Centers 
for Disease Control and Prevention, pers. 
obser.). When occupational contact with 
bats is unavoidable, rabies preexposure pro- 
phylaxis is advised (Table 1). 
PREVENTION 
Vaccination of pet animals provides a 
barrier to transmission of rabies to humans. 
This has provided a major mechanism for 
prevention by breaking the link between ra- 
bies cycles in wildlife and transmission to 
domestic animals; the latter providing a 
ready means to pass the infection on to hu- 
mans. 
One of the most exciting developments 
in recent decades is the demonstration that 
wildlife also can be vaccinated against ra- 
bies. Successful use of oral rabies vaccines 
(attenuated viruses or genetically engi- 
neered recombinants) delivered in edible 
baits is changing the geographic distribu- 
tion of rabies. In Europe and Canada, the 
incidence of rabies in red foxes has de- 
creased as a result of targeted use of oral 
rabies vaccines (Muller, 1994; Wilhelm and 
Schneider, 1990). In the United States, trials 
are being conducted, or are planned, in 
Massachusetts, New Jersey, and New York) 
to vaccinate wild raccoons. The goal is to 
create immune barriers to prevent or slow 
the dissemination of rabies. Results of ear- 
lier trials designed to evaluate vaccine safe- 
ty, efficacy, ecologic impact, and physical 
bait variables have been favorable (Rup- 
precht et al., 1992, 1993). Approval and li- 
censing of such vaccines may provide au- 
thorities with new mechanisms to deal with 
rabies in raccoons and other wildlife. For 
example, officials in New York are consid- 
ering several applications of oral vaccines 
to control rabies in red foxes at the border 
with Canada and have initiated programs 
using oral vaccine to interrupt rabies trans- 
mission among raccoons in two counties 
where the disease is now enzootic in this 
species. Similarly, the United States De- 
partment of Agriculture is funding a collab- 
orative project to interrupt the transmission 
cycle of rabies in coyotes in southern Texas 
through the use of an oral rabies vaccine. 
Rabies is the only disease for which vac- 
cination is effectively applied after expo- 
sure. Although each possible exposure to 
rabies should be evaluated by a physician, 
local or state public health officials can pro- 
vide additional information concerning the 
need for prophylaxis. In the United States, 
the following factors should be considered 
before specific antirabies treatment is initi- 
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TABLE 1.-Recommended rabies-preexposure-prophylaxis guide, United States, modified from that 
of the Advisory Committee on Immunization Practices. 
Preexposure 
Risk category Nature of risk Typical populations recommendations 
Continuous 
Frequent 
Infrequent (greater 
than population 
at large) 
Rare (population 
at large) 
Virus present continuously, of- 
ten in high concentrations; 
aerosol, mucous membrane, 
bite, or nonbite exposure; 
specific exposures may go 
unrecognized 
Exposure usually episodic, with 
source recognized, but expo- 
sure also may be unrecog- 
nized; aerosol, mucous mem- 
brane, bite, or nonbite 
exposure 
Exposure nearly always episod- 
ic with source recognized; 
mucous membrane, bite, or 
nonbite exposure 
Exposures always episodic; mu- 
cous membrane, or bite with 
source unrecognized 
Rabies research laboratory 
workers; rabies biologics 
production workers 
Rabies diagnostic laboratory 
workers, mammalogists, 
spelunkers, veterinarians 
and staff, and animal-con- 
trol and wildlife workers in 
rabies epizootic areas; trav- 
elers visiting foreign areas 
of enzootic rabies for >30 
days 
Veterinarians and animal-con- 
trol and wildlife workers in 
areas of low rabies enzoot- 
icity; veterinary students 
United States population at 
large, including persons in 
rabies epizootic areas 
Primary coursea; sero- 
logic testing every 6 
months; booster vac- 
cination when anti- 
body level falls be- 
low acceptable levelb 
Primary coursea; sero- 
logic testing or 
booster vaccination 
every 2 yearsb 
Primary coursea; no se- 
rologic testing or 
booster vaccination 
No vaccination neces- 
sary 
a IM (intramusuclar = HDCV (human diploid cell vaccine) or RVA (rabies vaccine, adsorbed), 1.0 ml (deltoid area), one each 
on days 0, 7, and 21 or 28. ID (intradermal) = HDCV, 0.1 ml, one each on days 0, 7, and 21 or 28. 
b Minimum acceptable antibody level is complete virus neutralization at a 1:5 serum dilution by RFFIT (rapid focus fluorescence 
inhibition test). Booster dose (IM = HDCV or RVA, 1.0 ml in deltoid area, day 0 only; or ID = HDCV, 0.1 ml, day 0 only) 
should be administered if the titer falls below this level. 
ated. Postexposure treatment is only nec- 
essary following a "true" exposure. The 
most important exposure is animal bite, 
which includes any penetration of the skin 
by teeth. Bites to the face and hands carry 
the highest risk, but the site of the bite 
should not influence the decision to begin 
treatment (Hattwick, 1974). Nonbite expo- 
sures include contact of saliva or other po- 
tentially infectious material (such as brain 
tissue) from a rabid animal with scratches, 
abrasions, open wounds, or mucous mem- 
branes and should be considered for treat- 
ment. Other contacts, such as petting a ra- 
bid animal and contact with the blood, 
urine, or feces of a rabid animal, do not 
constitute exposures and are not indications 
for prophylaxis. 
All bites by carnivores (especially rac- 
coons, skunks, and foxes) and bats must be 
considered possible exposures. Postexpo- 
sure prophylaxis (Table 2) should be initi- 
ated unless the exposure occurred in a 
country or region known to be free of ter- 
restrial rabies or in a part of the continental 
United States known to be free of terrestrial 
rabies and the results of testing of brain tis- 
sue from the animal responsible for the ex- 
posure will be available within 48 h. If the 
animal has been tested and shown not to be 
rabid, treatment is unnecessary and can be 
discontinued. Bat rabies exists in areas that 
are considered free of terrestrial rabies, and 
all bites or scratches from bats should be 
considered potential exposures. 
Signs of rabies in wild carnivores cannot 
be interpreted reliably; therefore, any such 
animal that bites or scratches a person 
should be killed at once (without unneces- 
sary damage to the head) and the brain sub- 
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TABLE 2.-Recommended rabies-postexposure-prophylaxis schedule, United States, modified from 
that of the Advisory Committee on Immunization Practices. 
Vaccination status Treatment Regimenc 
Not previously vaccinated 
Previously vaccinateda 
Local wound 
HRIGb 
Vaccine 
Local wound 
HRIG 
Vaccine 
All wounds should be thoroughly cleansed with soap 
and water 
20 IU/kg body weight; if anatomically feasible, up to 
one-half the dose should be administered around the 
wound(s) and the rest should be administered intra- 
muscularly in the gluteal area; no more than the rec- 
ommended dose should be given 
HDCV or RVAd, 1.0 ml, intramuscular (deltoid areae), 
one each on days 0, 3, 7, 14, and 28 
All wounds should be thoroughly cleansed with soap 
and water 
HRIG should not be administered 
HDCV or RVA, 1.0 ml, intramuscular (deltoid areae), 
one each on days 0 and 3. 
a Any person with a history of preexposure vaccination with HDCV or RVA; prior postexposure prophylaxis with HDCV or 
RVA; or previous vaccination with any other type of rabies vaccine and a documented history of antibody response to the prior 
vaccination. 
b Human rabies immune globulin. 
cThese regimens are applicable for all age groups, including children. 
d HDCV = human diploid cell vaccine; RVA = rabies vaccine, adsorbed. 
e The deltoid area is the preferred site of vaccination for adults and older children. For young children, the outer aspect of the 
thigh may be used. Vaccine should never be administered in the gluteal area. 
mitted for rabies testing. If the test results 
are negative, it can be assumed that the sa- 
liva contains no rabies virus, and the bitten 
person need not be treated. If the biting an- 
imal is particularly rare or valuable and the 
risk of rabies small, postexposure treatment 
can be administered to the bite victim in 
lieu of killing the animal for rabies testing 
(National Association of State Public 
Health Veterinarians, 1995). 
Rodents (such as squirrels, hamsters, 
guinea pigs, gerbils, chipmunks, rats, and 
mice) and lagomorphs (including rabbits 
and hares) are, with the exception of wood- 
chucks, almost never found to be rabid and 
have not been known to cause rabies in hu- 
mans in the United States. In all cases in- 
volving rodents, the state or local health de- 
partment should be consulted before a de- 
cision is made to initiate postexposure an- 
tirabies prophylaxis. 
Management of animals other than dogs 
and cats depends on the species, the cir- 
cumstances of the bite, and the epizootiol- 
ogy of rabies in the area. If the period of 
rabies-viral shedding for the species is un- 
known, the animal may be killed and tested 
rather than confined and observed, when it 
bites a human (Centers for Disease Control 
and Prevention, 1991; National Association 
of State Public Health Veterinarians, 1995). 
The likelihood that a domestic animal is 
infected with rabies varies from region to 
region. In areas where canine rabies is not 
enzootic (including virtually all of the Unit- 
ed States and its territories, with the excep- 
tion of southern Texas), a healthy domestic 
dog or cat that bites a person should be con- 
fined and observed for 10 days. Human 
treatment can be delayed pending the out- 
come of this confinement. If signs sugges- 
tive of rabies develop, the animal should be 
humanely killed and tested for rabies. Any 
stray or unwanted dog or cat that bites a 
person should be killed immediately and 
the head submitted for rabies examination 
(Centers for Disease Control and Preven- 
tion, 1991; National Association of State 
Public Health Veterinarians, 1995). 
As discussed earlier, exposures to dogs in 
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canine-rabies-enzootic areas outside the 
United States carry a much higher risk; 
some authorities, therefore, recommend that 
postexposure rabies treatment be initiated 
immediately following such exposures (Ta- 
ble 2). Treatment can be discontinued if the 
dog or cat remains healthy during the 10- 
day observation period. 
Preexposure rabies prophylaxis (tradi- 
tional vaccination) is recommended for per- 
sons, such as mammalogists, whose activi- 
ties bring them into frequent contact with 
rabies virus or potentially rabid wildlife, es- 
pecially raccoons, skunks, foxes, and bats 
(Table 1). It should be considered for per- 
sons visiting foreign areas for >30 days, 
where canine rabies is enzootic (Table 1). 
Persons visiting locations considered es- 
pecially hazardous or engaged in vocations 
that increase their risk of exposure should 
consider preexposure prophylaxis regard- 
less of the duration of their visit. 
OPPORTUNITIES FOR RESEARCH 
Despite the descriptive epidemiology of 
rabies in various species, our understanding 
of many aspects of the basic biology of in- 
fection and transmission of the rabies virus 
in wildlife is incomplete. Fundamental 
questions concerning the pathogenicity, im- 
mune response, transmission dynamics, and 
epizootiology of rabies remain unanswered. 
These questions have not been studied in 
part because most human exposures are rec- 
ognized and successfully treated. Conse- 
quently, public health and conservation ef- 
forts to reduce human exposure and to pre- 
vent animal disease, respectively, are seri- 
ously hampered by a lack of knowledge 
ranging from the molecular to the macro- 
geographic. 
As previously outlined, wildlife rabies in 
the United States has been characterized 
mainly by compiling reported positive test 
results from animals submitted to testing fa- 
cilities. Which animals are submitted and 
tested depends largely on public and mu- 
nicipal initiative, compromising the quality 
of such data. While these data are useful in 
documenting trends over time or space, 
they are of limited analytical value to eco- 
logic and epidemiologic research. Addition- 
al effort is required to estimate the inci- 
dence of disease, rather than counting the 
number of positive tests. Without system- 
atic sampling or surveillance of large 
groups of both healthy and sick animals, it 
becomes difficult to analyze the impact of 
rabies on animal populations. Well-de- 
signed surveys of wildlife populations 
would be useful in determining the preva- 
lence of infection, evaluating demographic 
differences in disease, and characterizing 
transmission dynamics. 
Although certain aspects of rabies-viral 
infection and pathogenesis in dogs and cats 
have been well-documented, at least three 
basic areas of research into wildlife rabies 
await further study. How does transmission 
occur? What impacts do infections have on 
various wildlife populations? How is virus 
circulation maintained? Existing dogma 
provides that most intraspecific transmis- 
sion of rabies virus in foxes, skunks, rac- 
coons, and bats occurs via bite. While this 
is a sound working hypothesis, little has 
been done to rigorously explore the possi- 
bility that grooming, nursing, or more ca- 
sual contact among these animals could 
transmit virus. We know even less about 
how infection alters the natural behavior of 
wildlife species, hence, their ability to pass 
on rabies virus. As an example, neither the 
population density of raccoons nor the pro- 
portion that are being infected has been de- 
fined in most settings. Similarly, strain-spe- 
cific variation in the periods of incubation 
and infectiousness of rabies-viral variants 
needs further study. Why rabies variants as- 
sociated with silver-haired bats have been 
implicated in the majority of the cases of 
indigenously-acquired human rabies in the 
United States is unclear. Information on the 
ecology and behavior of this species of bat 
is sparse. Efforts to understand and alter the 
transmission dynamics of rabies virus as 
well as its spread to other species would 
benefit enormously from such knowledge. 
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Secondly, the range of outcomes of nat- 
ural rabies-viral infection in wildlife species 
is not well understood. For most species, 
the proportion of individuals that survive 
infection and develop antibody or remain 
chronically infected is unknown. The exis- 
tence, among wildlife, of individuals that 
survive infection and become chronic car- 
riers, as has been demonstrated for dogs 
(Fekadu et al., 1992), is undocumented and, 
presumably, extremely rare. However, evi- 
dence suggests that not all infected rac- 
coons die of rabies, a phenomenon that 
could have a major impact on population- 
level processes (Bigler et al., 1973; Brown 
et al., 1990; Carey and McLean, 1983). 
Natural herd immunity would rise, and pre- 
viously-infected immune survivors could 
lower the rate of transmission. Various hy- 
potheses have been advanced to explain 
why incidence of rabies decreases follow- 
ing an initial period of intense transmission. 
If the mortality rate is high, decreased in- 
cidence may result from declines in popu- 
lation density and fewer exposed animals; 
furthermore, decreased contacts would oc- 
cur as the number of infectious and unin- 
fected animals is reduced. 
Finally, how and why does enzootic ra- 
bies persist? Perhaps small, unrecognized 
foci of transmission persist through a pro- 
cess of contagion, like that which occurs 
during epizootics. Enzootic raccoon rabies 
has persisted in the southeastern United 
States a half-century after its emergence, 
and periodic epizootic activity has been re- 
ported in the mid-Atlantic states during the 
past 2 decades. Yet, fox rabies never be- 
came enzootic in the Southeast following 
major enzootics in the 1960s. We lack the 
data necessary to explain many of these 
phenomena convincingly. 
Human-animal interactions resulting in 
rabies exposure are poorly defined. De- 
scriptions of the circumstances of human 
exposure exist, but little systematic inves- 
tigation of the ecology of rabid animal-hu- 
man interactions has been published. Re- 
search that compares reported human ex- 
posures with comparable unexposed per- 
sons, examining human activity, physical 
environment, and animal behavior, would 
help define human risk of infectious con- 
tacts. Systematic studies of indirect contact 
with rabid wildlife through pets and of non- 
bite contact with potentially infectious ma- 
terials also would be instructive. Efforts to 
more carefully document contact that may 
not be infectious should help reduce the ex- 
pense and anxiety associated with certain 
suspected exposures. 
Although an immunizing oral vaccine 
and attractive bait have been developed for 
raccoons, the design of applications and 
measurement of success in populations of 
raccoons are hindered without knowledge 
of the pathogenicity, immunogenicity, and 
demographic impact of natural rabies-viral 
infection. Because our knowledge in these 
realms is weak, neither the success nor fail- 
ure of wildlife-vaccination trials will be 
easily interpretable. The amount, timing, 
and habitat distribution of vaccine baits as 
well as the proportion of the raccoon pop- 
ulation that should be vaccinated to produce 
an impact need to be better defined. The 
knowledge gained from vaccination pro- 
grams for European and Canadian foxes 
cannot be applied without modification to 
the control of raccoon rabies in the United 
States. The behavior, population density, 
and habitats of the two species differ con- 
siderably. The peridomestic tendencies of 
raccoons suggest that effective interven- 
tions could be attempted in diverse envi- 
ronments, each posing special logistical 
problems. 
Ultimately, the objectives of any wild- 
life-vaccination campaign against rabies 
must be defined for each intervention. 
Should vaccination be aimed at decreasing 
transmission among wildlife, reducing 
wildlife disease and death, maintaining den- 
sities of wildlife populations, or lessening 
risk of human exposure? These goals are 
decidedly different and, in part, may be mu- 
tually inconsistent. There is obvious need 
for interaction with wildlife biologists and 
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mammalogists in the design and implemen- 
tation of these interventions. 
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